Atrovent HFA 17 mcg/INHAL Metered Dose Inhaler, 200 Actuations
RxNorm 836368
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 836368 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Atrovent HFA 17 mcg/INHAL Metered Dose Inhaler, 200 Actuations.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
200 ACTUAT Atrovent HFA 0.017 mg/ACTUAT Metered Dose Inhaler
(Atom ID: 2989254)
SBDPrescribable
Semantic Branded Drug (SBD):
200 ACTUAT ipratropium bromide 0.017 mg/ACTUAT Metered Dose Inhaler [Atrovent]
(Atom ID: 12364530)
SYPrescribable
Synonym (SY):
Atrovent 0.017 mg/ACTUAT Metered Dose Inhaler, 200 ACTUAT
(Atom ID: 2987955)
SYPrescribable
Synonym (SY):
Atrovent HFA 17 mcg per ACTUAT Metered Dose Inhaler, 200 ACTUAT
(Atom ID: 2989255)
PSNPrescribable
Prescribable Name (PSN):
Atrovent HFA 17 mcg/INHAL Metered Dose Inhaler, 200 Actuations
(Atom ID: 6366876)
Patient Education
Ipratropium Oral Inhalation
Ipratropium oral inhalation is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to the air sacs in the lungs). Ipratropium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
[Learn More]
* Please review the disclaimer below.